# Safety of Autologous Cord Blood Cells for Preterm Infants.

> **NCT03760900** · EARLY_PHASE1 · COMPLETED · sponsor: **Guangdong Women and Children Hospital** · enrollment: 15 (actual)

## Conditions studied

- Safety Issues
- Effect of Drugs
- Neonatal Death

## Interventions

- **COMBINATION_PRODUCT:** Autologous Umbilical Cord Blood Stem Cells Therapy

## Key facts

- **NCT ID:** NCT03760900
- **Lead sponsor:** Guangdong Women and Children Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01-01
- **Primary completion:** 2010-01-01
- **Final completion:** 2016-06-05
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03760900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03760900, "Safety of Autologous Cord Blood Cells for Preterm Infants.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03760900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*